Related Experiment Video

Updated: Jul 14, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons

N W Kowall1, P Hantraye, E Brouillet

  • 1Geriatric Research Education Clinical Center, Veterans Affairs Medical Center, Bedford, MA 01730, USA.

Neuroreport
|February 23, 2000
PubMed

Insights

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in baboons induced alpha-synuclein aggregation, modeling early Parkinson's disease pathology. This aggregation in degenerating neurons suggests a key step in Parkinson's disease progression.

Area of Science:

  • Neuroscience
  • Pathology
  • Neurodegenerative Diseases

Background:

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity is a model for Parkinson's disease (PD).
  • Alpha-synuclein is a key component of Lewy bodies (LB), the pathological hallmark of PD.
  • Previous studies showed MPTP-treated primates develop inclusions, but not true Lewy bodies.

Purpose of the Study:

  • To investigate the relationship between MPTP-induced neuronal degeneration and alpha-synuclein.
  • To define the role of alpha-synuclein in the substantia nigra following MPTP administration.
  • To model early stages of Lewy body formation in Parkinson's disease.

Main Methods:

  • Administration of MPTP to baboons.
  • Utilized a monoclonal alpha-synuclein antibody for immunohistochemical analysis.
  • Examined alpha-synuclein immunoreactivity in the substantia nigra.

Main Results:

  • MPTP-induced neuronal degeneration correlated with alpha-synuclein redistribution.
  • Alpha-synuclein shifted from its normal synaptic location to aggregates within degenerating neurons.
  • Observed aggregation of alpha-synuclein in the substantia nigra of MPTP-treated baboons.

Conclusions:

  • MPTP-induced alpha-synuclein aggregation models early Lewy body formation.
  • Alpha-synuclein aggregation may be a fundamental step in MPTP-induced neuronal degeneration.
  • This model provides insights into the pathogenesis of Parkinson's disease.

More Related Videos

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...